Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07696572 · ClinicalTrials.gov registry record
EUS Procedures Using RIVOS™ EUS Access Device
A clinical trial, sponsored by Orlando Health.
- Recruiting
- Registry status
- 30
- Enrollment target
NCT07696572: Recruiting study, sponsored by Orlando Health.
NCT07696572 is a clinical trial that is actively recruiting participants, run by Orlando Health. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07696572 is actively recruiting participants, sponsored by Orlando Health.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
Study Summary
This is a prospective study of patients undergoing EUS procedures using the RIVOS™ EUS access device.
Primary Outcome
Rate of technical success in patients undergoing EUS-guided procedures
Interventions
- DEVICE EUS-guided intervention using the RIVOS™ EUS access device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-07 |
| Est. Completion | 2027-12 |
What NCT07696572 shows while recruiting
NCT07696572 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which EUS-guided intervention using the RIVOS™ EUS access device is the first listed.
NCT07696572 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07696572 about?
NCT07696572 is a clinical study titled "EUS Procedures Using RIVOS™ EUS Access Device". This is a prospective study of patients undergoing EUS procedures using the RIVOS™ EUS access device.
What is the current status of trial NCT07696572?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2026-07. Estimated completion is 2027-12.
What interventions are being tested in trial NCT07696572?
The interventions under investigation include: EUS-guided intervention using the RIVOS™ EUS access device (DEVICE).
Who is sponsoring clinical trial NCT07696572?
This trial is sponsored by Orlando Health, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia